Advances in mCRPC Management: Recent Approvals, Emerging Therapies…
Nov 15, 2024 · There is an urgent unmet need for novel and targeted therapies for mCRPC, particularly for patients who have progressed on an ARPI. This need will persist as novel …
Treatment Selection Considerations in mCRPC | Targeted …
Jun 30, 2025 · For patients with other homologous recombination repair (HRR) mutations, similar combination regimens may be offered. Treatment choices are also influenced by symptom …
Targeted Therapies Both Refine and Raise Questions About CRPC Treatment …
Apr 16, 2025 · Evan Y. Yu, MD, discusses PARP inhibitor treatment selection and sequencing for patients with metastatic castration-resistant prostate cancer.
Treatment for Metastatic Castration-Resistant Prostate Cancer
Apr 17, 2025 · The treatment of metastatic castration-resistant prostate cancer (mCRPC) is different from other types of prostate cancer because it is neither curable nor fully responsive …
The Contemporary Treatment Landscape of mCRPC - Urology …
Feb 27, 2025 · Panelists discuss how the evolving treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) encompasses multiple therapeutic options including novel …
3 Things You Should Know About Advancing mCRPC Care: Targeted …
Jul 1, 2025 · Discover the latest advancements in metastatic castration-resistant prostate cancer care, including personalized treatment strategies and emerging therapies.
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment …
Jun 24, 2024 · Herein, we discuss the most recent advancements in mCRPC treatment, the mechanisms of action, the nuances of trials, and the direction in which this field is heading. We …
ESMO 2025: Optimized Use of Immunotherapy and Targeted Therapies in mCRPC
(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by Dr. Aurelius Omlin discussing …
How is mCRPC different than other types of Prostate Cancer? Prostate cancer starts as Localized Prostate Cancer. This is when it is only found in the prostate and surgery or radiation is used …
mCRPC: Key Pathways, Diagnostic Tools, and Evolving Treatments
Apr 29, 2025 · Explore the mechanisms driving mCRPC, the role of molecular markers in diagnosis, and the latest advancements in therapeutic strategies for improved outcomes.